Trials / Not Yet Recruiting
Not Yet RecruitingNCT07513454
A Phase 2 Study of HW211026 in Participants With Actinic Keratosis
A Multicenter, Randomized, Open-label, Parallel-group, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HW211026 Ointment in Patients With Actinic Keratosis.
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, open-label, parallel-group, Phase II clinical trial designed to evaluate the efficacy and safety of HW211026 in adult patients with actinic keratosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HW211026 | HW211026 ointment dose 1，applied topically on face once daily. |
| DRUG | HW211026 | HW211026 ointment dose 2，applied topically on face once daily. |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Source: ClinicalTrials.gov record NCT07513454. Inclusion in this directory is not an endorsement.